For its third fiscal quarter (ending September 30), Bausch Health Cos Inc (NYSE: BHC) has reported a -78% decline in E.P.S. from $-1.03 a year ago to $-0.23 in the current quarter. For the latest four quarters through September 30, E.P.S. were $-0.49 compared to $-2.65 a year ago — a decline of -82%.
Recent Price Action
Bausch Health Cos Inc (NYSE: BHC) stock closed at $8.17 on 10/30/24 after a slight gain of 0.1%. This advance was accompanied by normal trading volume. The stock has risen 0.7% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
BHC is expected to be an important Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
Bausch Health is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment